TESTBANK
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy-L. Wright
, TABLE OF CONTENT
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber........................................................................4
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................5
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
Chapter 4. Legal and Professional Issues in Prescribing...................................................................................... 14
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
Chapter 8. Herbal Therapies ................................................................................................................................ 28
Chapter 9. Cannabis............................................................................................................................................. 31
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
Chapter 14. Drugs Affecting the Respiratory System.......................................................................................... 61
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................. 83
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
Chapter 22. Drugs Affecting the Bones and Joints .............................................................................................. 92
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................101
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..........................................................105
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................108
Chapter 27. Drugs Used to Treat Eye and Ear-Disorders ....................................................................................111
Chapter 28. Anemia ............................................................................................................................................113
Chapter 29. Anxiety and Depression ..................................................................................................................116
Chapter 30. Attention Deficit-Hyperactivity-Disorder .......................................................................................120
Chapter 31. Asthma and Allergy ........................................................................................................................122
Chapter 32. Chronic Obstructive Pulmonary-Disease ........................................................................................125
Chapter 33. Contraception ..................................................................................................................................127
Chapter 34. COVID-19: Acute and Chronic.......................................................................................................130
Chapter 35. Dermatological Conditions .............................................................................................................134
Chapter 36. Diabetes Management .....................................................................................................................138
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer-Disease ........................................................................146
Chapter 38. Headaches .......................................................................................................................................149
Chapter 39. Heart Failure ...................................................................................................................................153
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome..............................................................158
Chapter 41. Menopausal Hormone Therapy .......................................................................................................161
,Chapter 42. Hyperlipidemia................................................................................................................................164
Chapter 43. Hypertension ...................................................................................................................................169
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................174
Chapter 45. Obesity ............................................................................................................................................177
Chapter 46. Pain Management: Acute and Chronic Pain ....................................................................................181
Chapter 47. Pneumonia.......................................................................................................................................185
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................187
Chapter 49. Substance Use Disorders .................................................................................................................190
Chapter 50. Tuberculosis ....................................................................................................................................195
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ...........197
Chapter 52. Urinary Tract Infections ..................................................................................................................200
Chapter 53. Women as Patients ..........................................................................................................................203
Chapter 54. Men as Patients ...............................................................................................................................207
Chapter 55. Pediatric Patients .............................................................................................................................209
Chapter 57. Geriatric Patients .............................................................................................................................213
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e sd sd sd sd Ch01
Chapter 1. The Role ofthe Advanced Practice Nurse asPrescriber
sd sd sd sd d
s sd sd sd sd sd
MULTIPLE CHOICE sd
1. Nurse practitioner-prescriptive authority is regulated by:
sd sd sd sd sd
A. The National Council of State Boards of Nursing
sd sd sd sd sd sd sd
B. The U.S. Drug Enforcement Administration
sd sd sd sd
C. TheState Board of Nursing for each state
sd sd sd sd sd sd sd
D. The State Board of Pharmacy sd sd sd sd
ANS: C s d PTS: 1 s d s d
2. The-benefits to the patient of having an advanced practice- sd sd sd sd sd sd sd sd
registered nurse (APRN) prescriber include: sd sd sd sd
A. Nursesknow- ds
moreabout pharmacologythanotherprescribersbecausetheytakeit both in their basi
ds sd sd ds sd ds ds sd ds sd sd sd sd
c nursing program and in their APRN program.
sd sd sd sd sd sd sd
B. Nurses careforthepatient from aholistic approach andincludethepatient in decis
sd ds sd sd sd sd sd sd sd sd ds sd sd sd
ion-making regarding their care. sd sd sd
C. APRNsare less likely-to prescribe narcotics and other-controlledsubstances.
ds sd sd sd sd sd sd ds
D. APRNsareabletoprescribe- ds sd sd ds
independentlyinallstates,whereas aphysician’s assistant needs to have a physic ds sd ds ds sd ds sd sd sd sd sd sd
ian supervising their practice.
sd sd sd
ANS: B s d PTS: 1 s d s d
3. Clinical judgment in prescribing includes:
sd sd sd sd
A. Factoring in the cost to the patient of the medication prescribed sd sd sd sd sd sd sd sd sd sd
B. Alwaysprescribing the newest medication available for the diseaseprocess
ds sd sd sd sd sd sd sd ds
C. Handing-out drug samples to poor patients sd sd sd sd sd
D. Prescribing all generic medications to cutcosts sd sd sd sd sd ds
ANS: A s d PTS: 1 s d s d
4. The process for choosing an effective drug fora disorder-includes:
sd sd sd sd sd sd sd sd sd
A. Asking the patient what drug they think would work best for-them
sd sd sd sd sd sd sd sd sd sd
B. Consultingnationally-recognized guidelines for diseasemanagement ds sd sd sd ds
C. Prescribingmedications that are available as samples beforewriting a prescription ds sd sd sd sd sd sd sd sd sd
D. Following-U.S. Drug-Enforcement Administration guidelines forprescribing sd sd sd sd ds
ANS: B s d PTS: 1 s d s d
5. Nonintentional nonadherence of drug therapy may occur-due to: sd sd sd sd sd sd sd
A. Belief-that medication does not work sd sd sd sd
B. Adverse drug reactions sd sd
C. Chronic conditions that require dailytherapy sd sd sd sd sd
D. Forgetfulness ordistraction sd ds
ANS: D s d PTS: 1 s d s d
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy-L. Wright
, TABLE OF CONTENT
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber........................................................................4
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................5
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
Chapter 4. Legal and Professional Issues in Prescribing...................................................................................... 14
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
Chapter 8. Herbal Therapies ................................................................................................................................ 28
Chapter 9. Cannabis............................................................................................................................................. 31
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................. 45
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
Chapter 14. Drugs Affecting the Respiratory System.......................................................................................... 61
Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................. 83
Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
Chapter 22. Drugs Affecting the Bones and Joints .............................................................................................. 92
Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................101
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..........................................................105
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................108
Chapter 27. Drugs Used to Treat Eye and Ear-Disorders ....................................................................................111
Chapter 28. Anemia ............................................................................................................................................113
Chapter 29. Anxiety and Depression ..................................................................................................................116
Chapter 30. Attention Deficit-Hyperactivity-Disorder .......................................................................................120
Chapter 31. Asthma and Allergy ........................................................................................................................122
Chapter 32. Chronic Obstructive Pulmonary-Disease ........................................................................................125
Chapter 33. Contraception ..................................................................................................................................127
Chapter 34. COVID-19: Acute and Chronic.......................................................................................................130
Chapter 35. Dermatological Conditions .............................................................................................................134
Chapter 36. Diabetes Management .....................................................................................................................138
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer-Disease ........................................................................146
Chapter 38. Headaches .......................................................................................................................................149
Chapter 39. Heart Failure ...................................................................................................................................153
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome..............................................................158
Chapter 41. Menopausal Hormone Therapy .......................................................................................................161
,Chapter 42. Hyperlipidemia................................................................................................................................164
Chapter 43. Hypertension ...................................................................................................................................169
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................174
Chapter 45. Obesity ............................................................................................................................................177
Chapter 46. Pain Management: Acute and Chronic Pain ....................................................................................181
Chapter 47. Pneumonia.......................................................................................................................................185
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................187
Chapter 49. Substance Use Disorders .................................................................................................................190
Chapter 50. Tuberculosis ....................................................................................................................................195
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ...........197
Chapter 52. Urinary Tract Infections ..................................................................................................................200
Chapter 53. Women as Patients ..........................................................................................................................203
Chapter 54. Men as Patients ...............................................................................................................................207
Chapter 55. Pediatric Patients .............................................................................................................................209
Chapter 57. Geriatric Patients .............................................................................................................................213
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e sd sd sd sd Ch01
Chapter 1. The Role ofthe Advanced Practice Nurse asPrescriber
sd sd sd sd d
s sd sd sd sd sd
MULTIPLE CHOICE sd
1. Nurse practitioner-prescriptive authority is regulated by:
sd sd sd sd sd
A. The National Council of State Boards of Nursing
sd sd sd sd sd sd sd
B. The U.S. Drug Enforcement Administration
sd sd sd sd
C. TheState Board of Nursing for each state
sd sd sd sd sd sd sd
D. The State Board of Pharmacy sd sd sd sd
ANS: C s d PTS: 1 s d s d
2. The-benefits to the patient of having an advanced practice- sd sd sd sd sd sd sd sd
registered nurse (APRN) prescriber include: sd sd sd sd
A. Nursesknow- ds
moreabout pharmacologythanotherprescribersbecausetheytakeit both in their basi
ds sd sd ds sd ds ds sd ds sd sd sd sd
c nursing program and in their APRN program.
sd sd sd sd sd sd sd
B. Nurses careforthepatient from aholistic approach andincludethepatient in decis
sd ds sd sd sd sd sd sd sd sd ds sd sd sd
ion-making regarding their care. sd sd sd
C. APRNsare less likely-to prescribe narcotics and other-controlledsubstances.
ds sd sd sd sd sd sd ds
D. APRNsareabletoprescribe- ds sd sd ds
independentlyinallstates,whereas aphysician’s assistant needs to have a physic ds sd ds ds sd ds sd sd sd sd sd sd
ian supervising their practice.
sd sd sd
ANS: B s d PTS: 1 s d s d
3. Clinical judgment in prescribing includes:
sd sd sd sd
A. Factoring in the cost to the patient of the medication prescribed sd sd sd sd sd sd sd sd sd sd
B. Alwaysprescribing the newest medication available for the diseaseprocess
ds sd sd sd sd sd sd sd ds
C. Handing-out drug samples to poor patients sd sd sd sd sd
D. Prescribing all generic medications to cutcosts sd sd sd sd sd ds
ANS: A s d PTS: 1 s d s d
4. The process for choosing an effective drug fora disorder-includes:
sd sd sd sd sd sd sd sd sd
A. Asking the patient what drug they think would work best for-them
sd sd sd sd sd sd sd sd sd sd
B. Consultingnationally-recognized guidelines for diseasemanagement ds sd sd sd ds
C. Prescribingmedications that are available as samples beforewriting a prescription ds sd sd sd sd sd sd sd sd sd
D. Following-U.S. Drug-Enforcement Administration guidelines forprescribing sd sd sd sd ds
ANS: B s d PTS: 1 s d s d
5. Nonintentional nonadherence of drug therapy may occur-due to: sd sd sd sd sd sd sd
A. Belief-that medication does not work sd sd sd sd
B. Adverse drug reactions sd sd
C. Chronic conditions that require dailytherapy sd sd sd sd sd
D. Forgetfulness ordistraction sd ds
ANS: D s d PTS: 1 s d s d
